Agnieszka Banbula

Title: Agnieszka Banbula: Innovator in Biochemical Research

Introduction

Agnieszka Banbula is a prominent inventor based in Athens, GA (US). She has made significant contributions to the field of biochemical research, particularly in the area of peptide bond cleavage and bacterial growth inhibition. With a total of 2 patents, her work has implications for both medical and biotechnological applications.

Latest Patents

Agnieszka's latest patents include innovative discoveries in the realm of prolyl tripeptidyl peptidases and dipeptidylpeptidases. The first patent, titled "Prolyl tripeptidyl peptidases nucleic acid of Porphyromonas gingivalis," provides isolated polypeptides and methods for reducing the growth of bacteria by inhibiting these enzymes. The second patent, "Dipeptidylpeptidases and methods of use," focuses on isolated polypeptides that cleave peptide bonds in specific target polypeptides, also aimed at inhibiting bacterial growth.

Career Highlights

Agnieszka Banbula is affiliated with the University of Georgia Research Foundation Inc., where she conducts her research. Her work has garnered attention for its potential applications in treating bacterial infections and advancing our understanding of peptide biochemistry.

Collaborations

Agnieszka collaborates with notable colleagues, including James Travis and Jan Stanislaw Potempa. These partnerships enhance her research capabilities and contribute to the advancement of her innovative projects.

Conclusion

Agnieszka Banbula's contributions to biochemical research through her patents and collaborations highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in medical and biotechnological applications.